Live Breaking News & Updates on பரோன் மூலதனம் குழு

Stay updated with breaking news from பரோன் மூலதனம் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Financial information in the Form S-1 registration statement and Change to Board of Directors


Share this article
Share this article
GAITHERSBURG, Md., July 12, 2021 /PRNewswire/  MaxCyte, Inc., (LSE: MXCT) (LSE: MXCN), a leading provider of platform technologies for cell engineering (
MaxCyte or the
Company ), today announced the public filing of a registration statement on Form S-1 with the Securities and Exchange Commission (the SEC ) for a proposed dual-listing and public offering of shares of common stock on the Nasdaq Stock Market (the offering ). The registration statement included a proposed change to the board of directors as well as unaudited financial information which is detailed below.
Financial information in the Form S-1 registration statement
The Company s Form S-1 registration statement contains unaudited consolidated financial statements for the period from 1 January 2021 to 31 March 2021 prepared in accordance with generally accepted accounting principles in the United States ( U.S. GAAP ). Such consolidated financial stat ....

United States , City Of , United Kingdom , Nick Adams , Duncan Monteith Matthew Odowd , Doug Doerfler , Amanda Murphy , Chris Welsh , Mary Jane Elliott , Emma Earl Freddy Crossley , Panmure Gordon , Ron Holtz , Rupert Dearden , Maxcyte Inc , London Stock Exchange , Myeloid Therapeutics Inc , Baron Capital Group , Company Form , Stifel Nicolaus Europe , T Rowe Price Associates Inc , Numis Securities , Consilium Strategic Communications , Price Associates , Arrowmark Partners , First Light Asset Management , Casdin Capital ,